Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-01-29
2008-01-29
Yu, Misook (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
Reexamination Certificate
active
07323551
ABSTRACT:
The present invention relates to compositions and methods for detecting and inhibiting squamous cell carcinoma using agents that target the laminin 5 alpha 3 G4-G5 domain.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 6120991 (2000-09-01), Carter et al.
patent: 6294356 (2001-09-01), Jones et al.
patent: 2002/0076736 (2002-06-01), Findell et al.
patent: WO0026342 (2000-05-01), None
Ahmed et al. “Chapter 39, Immunity to Viruses”Fundamental Immunology,4th edition, W. E. Paul, ed., Lippincott-Raven Publishers, 1999, Chapter 39, pp. 1295-1334.
Alama et al., “Antisense Oligonucleotides as Therapeutic Agents” (1997)Pharmacol Res.36(3):171-178.
Amano et al., “Bone morphogenetic protein 1 is an extracellular processing enzyme of the Laminin 5Y2 chain” 2000, J. Biol. Chem., 275: 22728-35.
Boado et al., “Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS” 1998,J. Pharm. Sci.87 (11): 1308-1315.
Cassidy et al., “Malanocytes adhere to and synthesize laminin-5 n vitro”Ep. Derm.1999, 8, 212-221.
Chan et al. “Laminin-6 and Laminin-5 are recognized by Autoantibodies in a subset of cicatricial pemphigoid”Society for Invs. Derm.,1997, 848-853.
Chen et al. “NC1 Domain of Type VII Collagen Binds to the β3 chain of laminin 5 via a Unique Subdomain Within the Fibronectin-like repeats” (1999)J. for Invest Derm. , 177-183.
Crooke, S. T., “Advances in understanding the pharmacological properties of antisense oligonucleotides” 1997,Adv. Pharmacol.40:1-49.
Dajee et al., “NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia”Naturevol. 421, 2003, 639-643.
Diederichsen, U., “Alanyl-PNA homoduplex: A-T Pairing with the N7-Regioisomer of Adenine” 1998,Bioorganic&Med. Chem. Lett., 8:165-168.
Fukushima et al., “Integrin α3β1-mediated interaction with lamin-5 stimulates adhesion, migration and invasion of malignant glioma cells” 1998,Int. J. Cancer,76: 63-72.
Huse et al., “Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda” 1989,Science,254: 1275-1281.
Jordan et al., “New Hetero-oligomeric peptide nucleic acids with improved binding properties to complementary DNA” (1997)Bioorg. Med. Chem. Lett. 7: 687-690.
Jordan et al. “Synthesis of new building blocks for peptide nucleic acids containing monomers with variations in the backbone” (1997)Bioorg. Med. Chem. Lett. 7: 637-627.
Kirtsching et al. “Anti-basement membrane autoantibodies in patients with anti-peiligrin cicatricial pemphigoid bind the α subunit of laminin 5”,J. Invest. Derm.(1995) 105, 543-548.
Kumar et al., “Pyrrolidine Nucleic Acids: DNA/PNA Oligomers with 2-hydroxylaminoethyl-4(thymin-1-yl) pyrrolidine-N-acetic acid” 2001,Organic Letters 3(9): 1269-1272.
Lavrosky et al., “Therapeutic potential and mechanism of action of oligonucleotides and ribozymes” 1997,Biochem. Mol. Med.,62(1):11-22.
Lee et al., “Polyamide Nucleic Acid Targeted to the Primer Binding Site of the HIV-1 RNA Genome Blocks in vitro HIV-1 Reverse Transcription” 1998,Biochemistry37 (3): 900-1010.
Li et al. “Laminin-10 is crucial for hair morphogenesis”the EMBO Journal,vol. 22, No. 10, pp. 2400-2410.
Maddox et al., “Elavated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein” 1983,J Exp Med,158: 1211.
Marcus-Sakura “Techniques for using antisense oligodeoxyribonucleotides to study gene expression” (1988)Anal. Biochem.172:289.
Marinkovch et al. Basement Membrane Proteins Kalinin and Nicein are Structurally and Immunologically Identical:Lab. Invest.,1993, vol. 69, No. 3, pp. 295-299.
Marinkovich et al., “The dermal-epidermal junction of human skin contains a novel laminin variant”J. Cell. Biol.vol. 119, No. 3, 1992, 695-703.
Marinkovich M. P. et al, “The Anchoring Filament Protein Kalinin is Synthesized and Secreted as a High Molecular Weight Precursor”,Journal of Biological Chemistry,vol. 267, No. 25, 1992, pp. 17900-17906.
McGowan et al. “Laminins and human disease”Microscopy Res. and Tech.51::262-279 (2000).
Meneguzzi et al. “Kalinin is abnormally expressed in epithelial basement membranes of Herliz's junctional epidermolysis bullosa patients”Exp. Derm.1992, pp. 221-229.
Meneguzzi et al., “Kalinin is abdnormally expressed in epithelial basement membranes of Herlizts junctional epidermolysis bullosa patients”, 1992,Exp. Derm,1, 221-229.
Miller, “Progress Toward Human Gene Therapy” 1990,Blood,76: 271.
Miquel et al., Establishment and Characterization of cell line LSV5 that retains the altered adhesive properties of human junctional epidermolysis bullosa keratinocytes,Exp. Cell. Res. ,224, 279-290 (1996).
Mizushima H. et al., Identification of Integrin-dependent and independent cell adhesion domains in cooh-terminal globular region of alminin-5 alpha3 chainCell Growth and Differentiation,The Association, Phil. Pa, US, vol. 8, No. 9, Sep. 1997, pp. 979-987.
Morris et al., “A new peptide vector for efficient delivery of oligonucleotides into mammalian cells” 1997,Nucl. Acids Res.25 (14): 2730-2736.
Nielsen, P. E. and G. Haaima, “Peptide nucleic acid (PNA). a DNA mimic with a pseudopeptide backbone” 1997,Chem. Soc. Rev.96:73-78.
O'Toole et al. “Laminin-5 inhibits human keratinocyte migration”Exp. Cell. Res.233, 330-339 (1997).
Orlandi et al., “Cloning immunoglobulin variable domains for expression by the polymerase chain reaction” 1989,Proc. Natl. Acad. Sci.86: 3833-3837.
Ortiz-Urda et al. “Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue”J. Clin. Invest.2003, vol. 111, No. 2, pp. 251-255.
Pardridge et al., “Vector-mediated delivery of a polyamide (“peptide”) nucleic acid analogue through the blood-brain barrier in vivo” 1995,Proc. Nat. Acad. Sci.92 (12):5592-5596.
Pyke et al., “Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas” 1995,Canc. Res.55: 4132-4139; Berndt et al., 1997,Invasion and Metastasis,17: 251-258.
Pyke, et al., “The γ2 chain of kalinin/Laminin 5 is preferentially expressed in invading malignant cells in human cancers” 1994,Am. J. Pathol.145(4): 782-791.
Rammensee; H., et al. “SYFPEITHI: database for MHC ligands and peptide motifs”: (1999)Immunogenetics,50:213-219.
Rossi et al., “Exploring the use of antisense, enzymatic RNA molecules (Ribozymes) as therapeutic agents” 1991,Antisense Res. Dev.1(3):285-288.
Rossi, “Therapeutic antisense and ribozymes” 1995,Br. Med. Bull.51 (1): 217-225.
Russell et al., “α6β4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of α3β1 integrin” 2003,J. Cell Sci.116 (17)3543-3556.
Ryan et al. “Cloning of the LamA3 Gene encoding the alpha3 chain of the adhesive ligand epiligrin”J. Bio. Chem.vol. 269, No. 36, pp. 22779-22787 (1984).
Slater et al., “The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine” 1998,J. Allergy Cli. Immunol.102 (3): 469-475.
Stoltzfus P. et al., Lamin-5 Gamma2 Chain Expression Facilitates Detection of Invasive Squamous Cell Carcinoma of the Uterine Cervix,Inernational Journal of Gynecological Pathology,vol. 23, No. 3, Jul. 2004, pp. 215-222.
Uckert and Walther, “Retrovirus-mediated gene transfer in cancer therapy” 1994,Pharacol. Ther.,63(3): 323-347.
van Hest et a
Bozicevic Field & Francis LLP
Halvorson Mark
Sherwood Pamela J.
The Board of Trustees of the Leland Stanford Junior University
Yu Misook
LandOfFree
Compositions and methods for inhibiting squamous cell carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inhibiting squamous cell carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibiting squamous cell carcinoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2779116